Back
Aligos Therapeutics, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Buy
78
ALGS
Aligos Therapeutics, Inc.
Last Price:
$10.70
Seasonality Move:
-0.28%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
Aligos Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.7 | Buy |
| 20-day SMA: | 8.38 | Buy |
| 50-day SMA: | 9.01 | Buy |
| 200-day SMA: | 8.6 | Buy |
| 8-day EMA: | 9.58 | Buy |
| 20-day EMA: | 9 | Buy |
| 50-day EMA: | 8.92 | Buy |
| 200-day EMA: | 10.46 | Sell |
Aligos Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 62.97 | Buy |
| Chaikin Money Flow: | -9378 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.91 - 9.49) | Buy |
| Bollinger Bands (100): | (7.89 - 10.43) | Buy |
Aligos Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics, Inc. Stock
Is Aligos Therapeutics, Inc. Stock a Buy?
-
Aligos Therapeutics, Inc. share price is 9.99 while ALGS 8-day simple moving average is 9.70, which is a Buy signal.
-
The stock price of ALGS is 9.99 while Aligos Therapeutics, Inc. 20-day SMA is 8.38, which makes it a Buy.
-
Aligos Therapeutics, Inc. 50-day simple moving average is 9.01 while ALGS share price is 9.99, making it a Buy technically.
-
ALGS stock price is 9.99 and Aligos Therapeutics, Inc. 200-day simple moving average is 8.60, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Buy
78
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Is Aligos Therapeutics, Inc. a Buy or a Sell?
-
Aligos Therapeutics, Inc. stock is rated a BuyThe current Aligos Therapeutics, Inc. [ALGS] share price is $9.99. The Score for ALGS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
Aligos Therapeutics, Inc. Stock Info
Market Cap:
61.5M
Price in USD:
9.99
Share Volume:
33.8K
Aligos Therapeutics, Inc. 52-Week Range
52-Week High:
46.80
52-Week Low:
3.76
Buy
78
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Aligos Therapeutics, Inc. Share Price Forecast
-
What is the Aligos Therapeutics, Inc. stock price today?The Aligos Therapeutics, Inc. stock price is 9.99 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics, Inc. is not overvalued.
Is Aligos Therapeutics, Inc. Stock a Buy?
-
Aligos Therapeutics, Inc. share price is 9.99 while ALGS 8-day exponential moving average is 9.58, which is a Buy signal.
-
The stock price of ALGS is 9.99 while Aligos Therapeutics, Inc. 20-day EMA is 9.00, which makes it a Buy.
-
Aligos Therapeutics, Inc. 50-day exponential moving average is 8.92 while ALGS share price is 9.99, making it a Buy technically.
-
ALGS stock price is 9.99 and Aligos Therapeutics, Inc. 200-day simple moving average is 10.46, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics, Inc.
Is Aligos Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.41 per share, and a decrease next year of $0.26 per share.
Technical Analysis of Aligos Therapeutics, Inc.
Should I short Aligos Therapeutics, Inc. stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Aligos Therapeutics, Inc. is a Buy
-
Aligos Therapeutics, Inc. Relative Strength Index (RSI) is 62.97, which suggest Aligos Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Aligos Therapeutics, Inc. is (6.91 - 9.49), which suggest Aligos Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Aligos Therapeutics, Inc. is (7.89 - 10.43), which suggest Aligos Therapeutics, Inc. is a Buy
* Aligos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.